Objectives

1 - A good vaccine candidate 

To identify the best active principle
(PSA or smallest peptide sequence)

To design a human compatible,
affordable, thermally stable and safe
formulation

To validate the immune crossprotection
properties of the vaccine

2 - Population selection tools

To design predictive immunoassays
for the identification of susceptible or
vaccinated individuals

To design a marker signature for
genetic susceptibility assessment

3- Vaccination assessment tool

To design the immunoassay for
vaccination follow-up.